#93
Quote from Dr Jonathan Oppenheimer, board-certified pathologist (fellowship in Urologic Pathology at Johns Hopkins), Medical Director and Chief Pathologist at Urologic Reference Lab (leading service provider of 2nd opinions of prostate biopsy pathology):
"The me-first imperative of professional trade organizations and healthcare entities run as businesses by external investors most interested in ROI with “skin in the game” — this is what perverts our present healthcare system and does a disservice to patients.
The transparency of the Internet will put an end to all these games. I’m looking forward to the return of medicine as a respected and suitably compensated honorable profession rather than its present meat-market (with patients as unsuspecting commodities, their body parts and “treatments” being marketed, bought and sold like widgets at a bazaar).
From my perspective, the first thing is to stop the creation of all these new prostate “cancer” patients. The medical industry can make a lot more money off someone if he has that label. (Please, please don’t misinterpret this. I am not saying that the diagnosis of “cancer” is not appropriate when it has a good chance of leading to treatment that benefits the patient.) The term just shouldn’t be used as widely as it currently is to describe a natural aging process that may not have significant potential to harm.
If taxpayer money is being spent, let it serve the interests of those who pay the taxes or society at large . If private money is spent, a transparent marketplace will enable an informed consumer to make reasonable decisions using their own values."